149 related articles for article (PubMed ID: 38625514)
1. STAT3 mediates ECM stiffness-dependent progression in ovarian cancer.
Chenchen S; Xueqian Q; Yahui L; Yi Y; Hui Z; Lanning B; Min C; Yangyang H
Mol Cell Biochem; 2024 Apr; ():. PubMed ID: 38625514
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow CD34
Zhang S; Ma X; Guo J; Yao K; Wang C; Dong Z; Zhu H; Fan F; Huang Z; Yang X; Qian J; Zou Y; Sun A; Ge J
Stem Cell Res Ther; 2017 Dec; 8(1):280. PubMed ID: 29237495
[TBL] [Abstract][Full Text] [Related]
3. Soft matrices inhibit cell proliferation and inactivate the fibrotic phenotype of deep endometriotic stromal cells in vitro.
Matsuzaki S; Canis M; Pouly JL; Darcha C
Hum Reprod; 2016 Mar; 31(3):541-53. PubMed ID: 26762314
[TBL] [Abstract][Full Text] [Related]
4. Assessing the roles of collagen fiber morphology and matrix stiffness on ovarian cancer cell migration dynamics using multiphoton fabricated orthogonal image-based models.
Alkmin S; Patankar MS; Campagnola PJ
Acta Biomater; 2022 Nov; 153():342-354. PubMed ID: 36152908
[TBL] [Abstract][Full Text] [Related]
5. The anti-tumor effect of OP-B on ovarian cancer in vitro and in vivo, and its mechanism: An investigation using network pharmacology-based analysis.
Yuan S; Xu Y; Yi T; Wang H
J Ethnopharmacol; 2022 Jan; 283():114706. PubMed ID: 34614446
[TBL] [Abstract][Full Text] [Related]
6. TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway.
Wei X; Lou H; Zhou D; Jia Y; Li H; Huang Q; Ma J; Yang Z; Sun C; Meng Y; Xu S; Yang X; Li X; Ji T; Guo Z; Gao Q
J Exp Clin Cancer Res; 2021 Sep; 40(1):292. PubMed ID: 34538264
[TBL] [Abstract][Full Text] [Related]
7. IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
Zou M; Zhang X; Xu C
Cell Oncol (Dordr); 2016 Feb; 39(1):47-57. PubMed ID: 26510945
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.
Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W
J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601
[TBL] [Abstract][Full Text] [Related]
9. FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer.
Lai H; Zhao X; Qin Y; Ding Y; Chen R; Li G; Labrie M; Ding Z; Zhou J; Hu J; Ma D; Fang Y; Gao Q
J Exp Clin Cancer Res; 2018 Feb; 37(1):32. PubMed ID: 29458390
[TBL] [Abstract][Full Text] [Related]
10. Mechanomimetic 3D Scaffolds as a Humanized In Vitro Model for Ovarian Cancer.
Paradiso F; Lenna S; Gazze SA; Garcia Parra J; Murphy K; Margarit L; Gonzalez D; Francis L; Taraballi F
Cells; 2022 Feb; 11(5):. PubMed ID: 35269446
[TBL] [Abstract][Full Text] [Related]
11. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis.
Zheng B; Geng L; Zeng L; Liu F; Huang Q
Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
[TBL] [Abstract][Full Text] [Related]
12. Fucoxanthin suppresses the malignant progression of ovarian cancer by inactivating STAT3/c-Myc signaling.
Zhang Z; Wang Y; Li J
Am J Transl Res; 2023; 15(4):2528-2540. PubMed ID: 37193140
[TBL] [Abstract][Full Text] [Related]
13. STAT3-induced SMYD3 transcription enhances chronic lymphocytic leukemia cell growth in vitro and in vivo.
Lin F; Wu D; Fang D; Chen Y; Zhou H; Ou C
Inflamm Res; 2019 Sep; 68(9):739-749. PubMed ID: 31218443
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness.
Zhang JY; Zhu WW; Wang MY; Zhai RD; Wang Q; Shen WL; Liu LK
J Transl Med; 2021 Dec; 19(1):513. PubMed ID: 34930321
[TBL] [Abstract][Full Text] [Related]
15. Directing osteogenic and myogenic differentiation of MSCs: interplay of stiffness and adhesive ligand presentation.
Rowlands AS; George PA; Cooper-White JJ
Am J Physiol Cell Physiol; 2008 Oct; 295(4):C1037-44. PubMed ID: 18753317
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo.
Zhang X; Liu P; Zhang B; Mao H; Shen L; Ma Y
Int J Mol Med; 2013 Sep; 32(3):623-8. PubMed ID: 23828376
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix stiffness controls VEGF
Bao M; Chen Y; Liu JT; Bao H; Wang WB; Qi YX; Lv F
Angiogenesis; 2022 Feb; 25(1):71-86. PubMed ID: 34170441
[TBL] [Abstract][Full Text] [Related]
18. Substrate stiffness regulates apoptosis and the mRNA expression of extracellular matrix regulatory genes in the rat annular cells.
Zhang YH; Zhao CQ; Jiang LS; Dai LY
Matrix Biol; 2011 Mar; 30(2):135-44. PubMed ID: 21055467
[TBL] [Abstract][Full Text] [Related]
19. RHPN2 Promotes Malignant Cell Behaviours in Ovarian Cancer by Activating STAT3 Signalling.
Yu F; Qiao P; Yin G; Sun Y; Yu X; Sun X; Chu Y; Wang Y
Onco Targets Ther; 2020; 13():11517-11527. PubMed ID: 33204106
[TBL] [Abstract][Full Text] [Related]
20. Expressions and clinical significances of STAT3 and Grim19 in epithelial ovarian cancer.
Wang Y; Yan Y; Yang M; Yang Z
3 Biotech; 2020 Jun; 10(6):246. PubMed ID: 32411570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
